Сагилия

Сагилия (Rasagiline) is an oral medication used to treat symptoms of Parkinson's disease. It belongs to the MAO-B inhibitor class, supporting dopamine activity in the brain. This product is manufactured by Medochemie Ltd. and sourced from the EU.

Rasagiline is primarily used to manage symptoms of Parkinson's disease, including tremors, stiffness, and movement difficulties. It may be prescribed alongside other medications to enhance their effects. Patients often ask, 'what is Rasagiline used for' as it targets dopamine regulation in the brain.

Rasagiline works by increasing dopamine levels in the brain, which can improve motor control and reduce symptoms like rigidity or slow movement. Some users may notice gradual improvements over weeks of consistent use. Individual responses can vary based on condition severity.

Store Rasagiline at room temperature away from moisture and direct light. Keep out of reach of children and pets. Avoid crushing or splitting tablets unless directed by a healthcare provider. Report any unusual reactions to a medical professional promptly.

Rasagiline may interact with certain antidepressants, opioids, or other MAO inhibitors, increasing the risk of side effects. Avoid alcohol and high-tyramine foods (e.g., aged cheeses) while taking this medication. Always inform your doctor about all current medications and supplements.